Physician-scientist #IBD #immunology #MondorMICI
Paris
Joined June 2009
- Tweets536
- Following427
- Followers273
- Likes2K
Mathieu Uzzan retweeted
🧩💊Anti-TNF therapy can induce #sarcoidosis-like lesions in #IBD
GETAID series (59 centres, n=14):
🔸71% dyspnea | 50% cough/fever
🔸86% mediastinal adenopathy
🔸Steroids → remission (median 84 days)
🔸No recurrences at 40 mo
📖 #OpenAccess 👉 bit.ly/4rAAwtN
ALT Visual Abstract
ALT Timeline of anti‐TNF exposure for the diagnosis of drug‐induced sarcoidosis‐like lesions
ALT Paraclinical signs of sarcoidosis‐like lesions
Mathieu Uzzan retweeted
#CGH4ALL @AGA_CGH
Breast cancer is the most common malignancy🚨 in IBD.
This study evaluated the risk factors for incident cancer in IBD w/ hx of breast Ca.
🔗doi.org/10.1016/j.cgh.2024.0…
Summary by @NAggarwalMD
@J_Kirchgesner @Pseksik @AlexandreNuzzo @snancey1 @MatFume @mat_uzz @VaysseCharlotte @SunandaKaneMD @UmaMahadevanIBD @Dcharabaty @IBD_Afzali @MRegueiroMD @JHashashMD @FarrayeIBD @ibdgijami @ibddocmaria @JPAchkarMD
@DrJordanAxelrad
Mathieu Uzzan retweeted
👩⚕️👨⚕️Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis
▪︎GETAID multi🏥 retrospective study
▪︎N=169 pts
▪︎SFCR at weeks 8-14: upadacitinib (55.2%) 🆚️filgotinib (33.3%)🆚️tofacitinib (50%)
▪︎upa was associated with ⬆️ odds of SFCR compared to Filgo
Mathieu Uzzan retweeted
Join us !
Open #Postdoc position in my lab (Paris, France), to work on the Role of the Gut #microbiota in Host Cells Energy Metabolism in Health and #IBD
see details here
🔽🔽🔽🔽
euraxess.ec.europa.eu/jobs/3…
please RT
Mathieu Uzzan retweeted
What an absolute honour and privilege to host Prof. Harry Sokol @h_sokol at the University of Calgary as part of the @SnyderInstitute endowed chair series . A packed auditorium listening to a masterful talk on the gut microbiota and IBD. Harry is trailblazing the field .
Mathieu Uzzan retweeted
🌟 The #ECCO topical review on IBD Predictive Models has been published in @JCC_IBD!
🔍 In this review, we
1️⃣ Summarized all current models
2️⃣ Identified relevant methodology
3️⃣ Provided guidance for future models
🙏 Huge thanks to the team!
academic.oup.com/ecco-jcc/ad…
Mathieu Uzzan retweeted
Elles sont médecins, chercheuses et scientifiques à @GustaveRoussy.
💬 « J'ai été baignée dans cet univers féminin, avec ces femmes très fortes et très brillantes. »
À l'occasion de la Journée internationale des femmes et des filles de science, découvrez le portrait de la Dr @CBigenwald ⤵
Congrats SURVI guys
1st patient included in the 1st randomized controlled trial in acute mesenteric ischemia! “ORal antibiotics In Acute Mesenteric Ischemia: a multicenter randomized controlled trial” #ORIAMI @AlexandreNuzzo @APHP #FHUTSUNAMI @oliviercorcos #SURVI @UP_Medecine
Mathieu Uzzan retweeted
1/3 Thrilled to share exciting new work in @Nature by @TouficMayassi, @li_chenhao, Åsa Segerstolpe, et al. Spatial profiling of mouse intestine reveals a landscape robust to perturbations in homeostatic drivers & adaptable in a spatially-restricted manner bit.ly/48ZzJKc
Mathieu Uzzan retweeted
📢Thrilled to share our work on the ontogeny, reactivity, and function of #IgA subclasses in homeostasis and #IBD! Huge thanks to Andrea, all our amazing collaborators, and @JExpMed for their support throughout the extended revision process! It's time to celebrate🥳!
Tejedor Vaquero, Neuman, Mehr, Cerutti, @GMagri_Immuno @HMar_research et al. show that gut IgA1 & IgA2 subclasses co-emerge early in life, largely derive from clonally related and somatically mutated plasma cells in adults, & show unique changes in #IBS. hubs.la/Q02YM2zm0
Happy to participate to this important and great team effort with incredible European colleagues and patients representatives @Y_ECCO_IBD !
Mathieu Uzzan retweeted
Very happy this publication officially kicks off the @CollibriIbd consortium. Let’s continu collaborative research to move the needle for the benefit of our patients !
Characterisation of #IBD #heterogeneity using serum #proteomics, a first study by the @CollibriIbd consortium. A multicentre study by Salomon and Sudhakar et al. @jonashalfvarson @SeverineVermei1 @bverstockt
academic.oup.com/ecco-jcc/ad…
Mathieu Uzzan retweeted
Please RT 🙏!📢My lab at @UniBarcelona is seeking a highly motivated postdoc to lead an exciting new public-private collaborative project (UB, CRG, CSIC, OrikineBio) aimed at testing a potentially game-changing therapy for IBD. If interested, please contact me at [email protected].
Congrats! Huge achievement 👏 👏
Delighted to announce that I've been awarded an @ERC_Research Starting Grant of ~1.5M € for my project FORECAST. I will develop in the next 5y a new framework using multiple sources of #RWD to assess the benefit-risk balance of #IBD treatments. #ERCStG
erc.europa.eu/news-events/ne…
Mathieu Uzzan retweeted
Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: the ERIC study
CD patients from Saint-Antoine and Beaujon Hospital comparing Early vs Late resections
onlinelibrary.wiley.com/doi/…
@APandT
@PSeksik @J_Kirchgesner @h_sokol
A true legend ⭐️
Today marks the last day of Laurent Beaugerie at @HopSaintAntoine. An #IBD legend is retiring after more than 40 years at @APHP. Immensely grateful for his mentorship and support since 15 years. Stay tuned for his new exciting professional chapter!
Mathieu Uzzan retweeted
Les inscriptions pour la Masterclass du GETAID sont lancées ! 🥳
Au programme : mises au point, échanges avec les experts, ateliers,...
Le programme complet disponible ici : getaid.org/actualites/master…
Mathieu Uzzan retweeted
Not sure about FMT, but, with @MatthieuAllez and the #REMIND group, we will soon start a study evaluating the effects of Faecalibacterium prausnitzii in postoperative settings